Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
Financial Results for the Year Ended December 31, 2023
- Financial Results for the Year Ended December 31, 2023
Revenue was $76.0 million in 2023 compared to $412.5 million in 2022. - Higher interest income in 2023 was due to income earned on higher cash resources and at higher rates of return in 2023.
- “We are happy to report a continued reduction of our operating cash burn and operating losses during 2023 compared to 2022,” said Chris Astle, Ph.D., Senior Vice President and Chief Financial Officer of Zymeworks.
- Reconciliations between historical GAAP and non-GAAP information are contained at the end of this press release following the accompanying financial data.